{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:32:21Z","timestamp":1790994741040,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Necroptosis is a kind of programmed cell death that causes the release of damage-associated molecular patterns and inflammatory disease including skin inflammation. Activation of receptor-interacting serine\/threonine kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL) is the hallmark of tumour necrosis factor \u03b1 (TNF)-induced necroptosis. Here, we screened a small-molecule compound library and found that saracatinib inhibited TNF-induced necroptosis. By targeting MLKL, Saracatinib interfered with the phosphorylation, translocation, and oligomerization of MLKL induced by TNF. Consistently, mutation of the saracatinib-binding site of MLKL reduced the inhibitory effect of saracatinib on TNF-induced necroptosis. In an imiquimod (IMQ)-induced psoriasis mouse model, saracatinib effectively blocked MLKL phosphorylation and inflammatory responses in vivo. Taken together, these findings indicate that saracatinib inhibits necroptosis by targeting MLKL, providing a potential therapeutic approach for skin inflammation-related diseases such as psoriasis.<\/jats:p>","DOI":"10.1038\/s41419-024-06514-y","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T14:03:46Z","timestamp":1707401026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL"],"prefix":"10.1038","volume":"15","author":[{"given":"Jingyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeteng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofa","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3746-8682","authenticated-orcid":false,"given":"Lanqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-272X","authenticated-orcid":false,"given":"Lisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"6514_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/ni.2159","volume":"12","author":"J Han","year":"2011","unstructured":"Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol. 2011;12:1143\u20139.","journal-title":"Nat Immunol"},{"key":"6514_CR2","doi-asserted-by":"publisher","first-page":"101855","DOI":"10.1016\/j.arr.2023.101855","volume":"86","author":"R Gupta","year":"2023","unstructured":"Gupta R, Kumari S, Tripathi R, Ambasta RK, Kumar P. Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases. Ageing Res Rev. 2023;86:101855.","journal-title":"Ageing Res Rev"},{"key":"6514_CR3","doi-asserted-by":"crossref","unstructured":"Samson AL, Garnish SE, Hildebrand JM, Murphy JM. Location, location, location: A compartmentalized view of TNF-induced necroptotic signaling. Sci Signal. 2021;14.","DOI":"10.1126\/scisignal.abc6178"},{"key":"6514_CR4","doi-asserted-by":"publisher","first-page":"e76841","DOI":"10.1371\/journal.pone.0076841","volume":"8","author":"DM Moquin","year":"2013","unstructured":"Moquin DM, McQuade T, Chan FK. CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS One. 2013;8:e76841.","journal-title":"PLoS One"},{"key":"6514_CR5","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.celrep.2015.11.009","volume":"13","author":"P Draber","year":"2015","unstructured":"Draber P, Kupka S, Reichert M, Draberova H, Lafont E, de Miguel D, et al. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes. Cell Rep. 2015;13:2258\u201372.","journal-title":"Cell Rep"},{"key":"6514_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325:332\u20136.","journal-title":"Science"},{"key":"6514_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 2009;137:1100\u201311.","journal-title":"Cell"},{"key":"6514_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137:1112\u201323.","journal-title":"Cell"},{"key":"6514_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148:213\u201327.","journal-title":"Cell"},{"key":"6514_CR10","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA. 2012;109:5322\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6514_CR11","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.1074\/jbc.M112.435545","volume":"288","author":"W Chen","year":"2013","unstructured":"Chen W, Zhou Z, Li L, Zhong CQ, Zheng X, Wu X, et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem. 2013;288:16247\u201361.","journal-title":"J Biol Chem"},{"key":"6514_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2016.05.011","volume":"20","author":"S Nogusa","year":"2016","unstructured":"Nogusa S, Thapa RJ, Dillon CP, Liedmann S, Oguin TH 3rd, Ingram JP, et al. RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus. Cell Host Microbe. 2016;20:13\u201324.","journal-title":"Cell Host Microbe"},{"key":"6514_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ncb2883","volume":"16","author":"Z Cai","year":"2014","unstructured":"Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol. 2014;16:55\u201365.","journal-title":"Nat Cell Biol"},{"key":"6514_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54:133\u201346.","journal-title":"Mol Cell"},{"key":"6514_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/cr.2013.171","volume":"24","author":"X Chen","year":"2014","unstructured":"Chen X, Li W, Ren J, Huang D, He WT, Song Y, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014;24:105\u201321.","journal-title":"Cell Res"},{"key":"6514_CR16","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/cr.2013.91","volume":"23","author":"J Wu","year":"2013","unstructured":"Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y, et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 2013;23:994\u20131006.","journal-title":"Cell Res"},{"key":"6514_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2019.05.022","volume":"75","author":"A Najafov","year":"2019","unstructured":"Najafov A, Mookhtiar AK, Luu HS, Ordureau A, Pan H, Amin PP, et al. TAM Kinases Promote Necroptosis by Regulating Oligomerization of MLKL. Mol Cell. 2019;75:457\u201368.e4.","journal-title":"Mol Cell"},{"key":"6514_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molcel.2018.05.010","volume":"70","author":"CM Dovey","year":"2018","unstructured":"Dovey CM, Diep J, Clarke BP, Hale AT, McNamara DE, Guo H, et al. MLKL Requires the Inositol Phosphate Code to Execute Necroptosis. Mol Cell. 2018;70:936\u201348.e7.","journal-title":"Mol Cell"},{"key":"6514_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.386","volume":"7","author":"AV Jacobsen","year":"2016","unstructured":"Jacobsen AV, Lowes KN, Tanzer MC, Lucet IS, Hildebrand JM, Petrie EJ, et al. HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death. Cell Death Dis. 2016;7:e2051.","journal-title":"Cell Death Dis"},{"key":"6514_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","volume":"190","author":"MK Khoury","year":"2020","unstructured":"Khoury MK, Gupta K, Franco SR, Liu B. Necroptosis in the Pathophysiology of Disease. Am J Pathol. 2020;190:272\u201385.","journal-title":"Am J Pathol"},{"key":"6514_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature20558","volume":"540","author":"J Lin","year":"2016","unstructured":"Lin J, Kumari S, Kim C, Van TM, Wachsmuth L, Polykratis A, et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature. 2016;540:124\u20138.","journal-title":"Nature"},{"key":"6514_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nature20559","volume":"540","author":"K Newton","year":"2016","unstructured":"Newton K, Wickliffe KE, Maltzman A, Dugger DL, Strasser A, Pham VC, et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature. 2016;540:129\u201333.","journal-title":"Nature"},{"key":"6514_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13608","volume":"513","author":"M Dannappel","year":"2014","unstructured":"Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature. 2014;513:90\u20134.","journal-title":"Nature"},{"key":"6514_CR24","doi-asserted-by":"crossref","unstructured":"Devos M, Tanghe G, Gilbert B, Dierick E, Verheirstraeten M, Nemegeer J, et al. Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation. J Exp Med. 2020;217.","DOI":"10.1084\/jem.20191913"},{"key":"6514_CR25","doi-asserted-by":"publisher","first-page":"245ra95","DOI":"10.1126\/scitranslmed.3008227","volume":"6","author":"N Saito","year":"2014","unstructured":"Saito N, Qiao H, Yanagi T, Shinkuma S, Nishimura K, Suto A, et al. An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci Transl Med. 2014;6:245ra95.","journal-title":"Sci Transl Med"},{"key":"6514_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2328-0","volume":"11","author":"X Duan","year":"2020","unstructured":"Duan X, Liu X, Liu N, Huang Y, Jin Z, Zhang S, et al. Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis. 2020;11:134.","journal-title":"Cell Death Dis"},{"key":"6514_CR27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cpt.1852","volume":"108","author":"K Weisel","year":"2020","unstructured":"Weisel K, Berger S, Papp K, Maari C, Krueger JG, Scott N, et al. Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled Study. Clin Pharmacol Ther. 2020;108:808\u201316.","journal-title":"Clin Pharmacol Ther"},{"key":"6514_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, et al. A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimers Res Ther. 2015;7:35.","journal-title":"Alzheimers Res Ther"},{"key":"6514_CR29","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.202010-3832OC","volume":"206","author":"F Ahangari","year":"2022","unstructured":"Ahangari F, Becker C, Foster DG, Chioccioli M, Nelson M, Beke K, et al. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022;206:1463\u201379.","journal-title":"Am J Respir Crit Care Med"},{"key":"6514_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41423-019-0237-x","volume":"17","author":"D Yang","year":"2020","unstructured":"Yang D, Liang Y, Zhao S, Ding Y, Zhuang Q, Shi Q, et al. ZBP1 mediates interferon-induced necroptosis. Cell Mol Immunol. 2020;17:356\u201368.","journal-title":"Cell Mol Immunol"},{"key":"6514_CR31","doi-asserted-by":"publisher","first-page":"E3206","DOI":"10.1073\/pnas.1407068111","volume":"111","author":"S McComb","year":"2014","unstructured":"McComb S, Cessford E, Alturki NA, Joseph J, Shutinoski B, Startek JB, et al. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc Natl Acad Sci USA. 2014;111:E3206\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6514_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14329","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ, Chen X, et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun. 2017;8:14329.","journal-title":"Nat Commun"},{"key":"6514_CR33","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/cdd.2014.70","volume":"21","author":"WD Cook","year":"2014","unstructured":"Cook WD, Moujalled DM, Ralph TJ, Lock P, Young SN, Murphy JM, et al. RIPK1- and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ. 2014;21:1600\u201312.","journal-title":"Cell Death Differ"},{"key":"6514_CR34","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/cdd.2014.77","volume":"21","author":"XN Wu","year":"2014","unstructured":"Wu XN, Yang ZH, Wang XK, Zhang Y, Wan H, Song Y, et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. 2014;21:1709\u201320.","journal-title":"Cell Death Differ"},{"key":"6514_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013;39:443\u201353.","journal-title":"Immunity"},{"key":"6514_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84\u20137.","journal-title":"Science"},{"key":"6514_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","volume":"26","author":"A Murao","year":"2021","unstructured":"Murao A, Aziz M, Wang H, Brenner M, Wang P. Release mechanisms of major DAMPs. Apoptosis. 2021;26:152\u201362.","journal-title":"Apoptosis"},{"key":"6514_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/15548627.2020.1725381","volume":"17","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhou H, Zheng H, Zhou X, Shen G, Teng X, et al. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin in flammation. Autophagy. 2021;17:529\u201352.","journal-title":"Autophagy"},{"key":"6514_CR39","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14:2994\u20133006.","journal-title":"Mol Oncol"},{"key":"6514_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2217\/bmm-2020-0360","volume":"15","author":"K Bubova","year":"2021","unstructured":"Bubova K, Storkanova H, Oreska S, Spiritovic M, Hermankova B, Mintalova K, et al. Plasma heat shock protein 90 levels in patients with spondyloarthritis and their relation to structural changes: a cross-sectional study. Biomark Med. 2021;15:5\u201313.","journal-title":"Biomark Med"},{"key":"6514_CR41","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol. 2009;182:5836\u201345.","journal-title":"J Immunol"},{"key":"6514_CR42","doi-asserted-by":"publisher","first-page":"748772","DOI":"10.3389\/fphar.2021.748772","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Zong J, Ye W, Fu Y, Gu X, Pan W, et al. Pithecellobium clypearia: Amelioration Effect on Imiquimod-Induced Psoriasis in Mice Based on a Tissue Metabonomic Analysis. Front Pharmacol. 2021;12:748772.","journal-title":"Front Pharmacol"},{"key":"6514_CR43","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"6514_CR44","doi-asserted-by":"crossref","unstructured":"Tokuyama M, Mabuchi T. New Treatment Addressing the Pathogenesis of Psoriasis. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21207488"},{"key":"6514_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"6514_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014;56:481\u201395.","journal-title":"Mol Cell"},{"key":"6514_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","volume":"41","author":"S Martens","year":"2020","unstructured":"Martens S, Hofmans S, Declercq W, Augustyns K, Vandenabeele P. Inhibitors Targeting RIPK1\/RIPK3: Old and New Drugs. Trends Pharmacol Sci. 2020;41:209\u201324.","journal-title":"Trends Pharmacol Sci"},{"key":"6514_CR48","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s42003-023-05353-5","volume":"6","author":"F Huang","year":"2023","unstructured":"Huang F, Liang J, Lin Y, Chen Y, Hu F, Feng J, et al. Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis. Commun Biol. 2023;6:972.","journal-title":"Commun Biol"},{"key":"6514_CR49","doi-asserted-by":"publisher","first-page":"15072","DOI":"10.1073\/pnas.1408987111","volume":"111","author":"JM Hildebrand","year":"2014","unstructured":"Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P, et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci USA. 2014;111:15072\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6514_CR50","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1039\/C7CC00667E","volume":"53","author":"B Yan","year":"2017","unstructured":"Yan B, Liu L, Huang S, Ren Y, Wang H, Yao Z, et al. Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein. Chem Commun (Camb). 2017;53:3637\u201340.","journal-title":"Chem Commun (Camb)"},{"key":"6514_CR51","doi-asserted-by":"publisher","first-page":"12747","DOI":"10.1021\/acs.jmedchem.2c00548","volume":"65","author":"B Cui","year":"2022","unstructured":"Cui B, Yan B, Wang K, Li L, Chen S, Zhang Z. Discovery of a New Class of Uracil Derivatives as Potential Mixed Lineage Kinase Domain-like Protein (MLKL) Inhibitors. J Med Chem. 2022;65:12747\u201380.","journal-title":"J Med Chem"},{"key":"6514_CR52","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1021\/jm060434q","volume":"49","author":"LF Hennequin","year":"2006","unstructured":"Hennequin LF, Allen J, Breed J, Curwen J, Fennell M, Green TP, et al. N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src\/Abl kinase inhibitor. J Med Chem. 2006;49:6465\u201388.","journal-title":"J Med Chem"},{"key":"6514_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2017.11.008","volume":"110","author":"S Sharma","year":"2018","unstructured":"Sharma S, Carlson S, Puttachary S, Sarkar S, Showman L, Putra M, et al. Role of the Fyn-PKCdelta signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy. Neurobiol Dis. 2018;110:102\u201321.","journal-title":"Neurobiol Dis"},{"key":"6514_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropharm.2017.11.042","volume":"130","author":"LM Smith","year":"2018","unstructured":"Smith LM, Zhu R, Strittmatter SM. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer\u2019s model. Neuropharmacology. 2018;130:54\u201361.","journal-title":"Neuropharmacology"},{"key":"6514_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40478-020-00976-9","volume":"8","author":"SJ Tang","year":"2020","unstructured":"Tang SJ, Fesharaki-Zadeh A, Takahashi H, Nies SH, Smith LM, Luo A, et al. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy. Acta Neuropathol Commun. 2020;8:96.","journal-title":"Acta Neuropathol Commun"},{"key":"6514_CR56","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, et al. Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci. 2017;20:1236\u201346.","journal-title":"Nat Neurosci"},{"key":"6514_CR57","doi-asserted-by":"publisher","first-page":"113203","DOI":"10.1016\/j.biopha.2022.113203","volume":"152","author":"R Richard","year":"2022","unstructured":"Richard R, Mousa S. Necroptosis in Alzheimer\u2019s disease: Potential therapeutic target. Biomed Pharmacother. 2022;152:113203.","journal-title":"Biomed Pharmacother"},{"key":"6514_CR58","doi-asserted-by":"crossref","unstructured":"Rendon A, Schakel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20061475"},{"key":"6514_CR59","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chembiol.2005.05.018","volume":"12","author":"P Gallinari","year":"2005","unstructured":"Gallinari P, Lahm A, Koch U, Paolini C, Nardi MC, Roscilli G, et al. A functionally orthogonal estrogen receptor-based transcription switch specifically induced by a nonsteroid synthetic ligand. Chem Biol. 2005;12:883\u201393.","journal-title":"Chem Biol"},{"key":"6514_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem"},{"key":"6514_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/cr.2014.17","volume":"24","author":"L Li","year":"2014","unstructured":"Li L, Chen W, Liang Y, Ma H, Li W, Zhou Z, et al. The Gbetagamma-Src signaling pathway regulates TNF-induced necroptosis via control of necrosome translocation. Cell Res. 2014;24:417\u201332.","journal-title":"Cell Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06514-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06514-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06514-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T17:02:38Z","timestamp":1707670958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06514-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["6514"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-06514-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed in accordance with protocols approved by Institutional Animal Ethical Committee of Fujian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"122"}}